Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Peripheral NeuropathyHIV Infections
Interventions
DRUG

pregabalin

75mg BID, titrated up to 300mg according to individual response and tolerability

Trial Locations (37)

10018

Pfizer Investigational Site, New York

10021

Pfizer Investigational Site, New York

10029

Pfizer Investigational Site, New York

14642

Pfizer Investigational Site, Rochester

19104

Pfizer Investigational Site, Philadelphia

30309

Pfizer Investigational Site, Atlanta

32960

Pfizer Investigational Site, Vero Beach

33133

Pfizer Investigational Site, Miami

33407

Pfizer Investigational Site, West Palm Beach

34695

Pfizer Investigational Site, Safety Harbor

60611

Pfizer Investigational Site, Chicago

60612

Pfizer Investigational Site, Chicago

63110

Pfizer Investigational Site, St Louis

72207

Pfizer Investigational Site, Little Rock

75204

Pfizer Investigational Site, Dallas

78229

Pfizer Investigational Site, San Antonio

78705

Pfizer Investigational Site, Austin

80262

Pfizer Investigational Site, Denver

85023

Pfizer Investigational Site, Phoenix

90025

Pfizer Investigational Site, Los Angeles

90028

Pfizer Investigational Site, Los Angeles

90069

Pfizer Investigational Site, West Hollywood

92103

Pfizer Investigational Site, San Diego

94117

Pfizer Investigational Site, San Francisco

98104

Pfizer Investigational Site, Seattle

95817-1460

Pfizer Investigational Site, Sacramento

94305-5235

Pfizer Investigational Site, Stanford

32504-5719

Pfizer Investigational Site, Pensacola

21287-7609

Pfizer Investigational Site, Baltimore

02215-3318

Pfizer Investigational Site, Boston

01107

Pfizer Investigational Site, Springfield

63110-1010

Pfizer Investigational Site, St Louis

75208-4234

Pfizer Investigational Site, Dallas

75390-9036

Pfizer Investigational Site, Dallas

00716

Pfizer Investigational Site, Ponce

00909-1711

Pfizer Investigational Site, San Juan

00936

Pfizer Investigational Site, San Juan

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00264875 - Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy | Biotech Hunter | Biotech Hunter